These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28198061)

  • 1. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
    Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
    Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
    Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
    Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities.
    Tamasi G; Bernini C; Corbini G; Owens NF; Messori L; Scaletti F; Massai L; Giudice PL; Cini R
    J Inorg Biochem; 2014 May; 134():25-35. PubMed ID: 24518539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
    Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
    Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs.
    Arion VB; Dobrov A; Göschl S; Jakupec MA; Keppler BK; Rapta P
    Chem Commun (Camb); 2012 Sep; 48(68):8559-61. PubMed ID: 22797078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
    Büchel GE; Kossatz S; Sadique A; Rapta P; Zalibera M; Bucinsky L; Komorovsky S; Telser J; Eppinger J; Reiner T; Arion VB
    Dalton Trans; 2017 Sep; 46(35):11925-11941. PubMed ID: 28850133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
    Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
    Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties.
    Parveen S; Tong KKH; Khawar Rauf M; Kubanik M; Shaheen MA; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG
    Chem Asian J; 2019 Apr; 14(8):1262-1270. PubMed ID: 30706633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
    Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
    Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ruthenium(III) complex with a tridentate dianionic P,O,O-ligand showing high cytotoxic activity.
    van Rijn JA; Marqués-Gallego P; Reedijk J; Lutz M; Spek AL; Bouwman E
    Dalton Trans; 2009 Dec; (48):10727-30. PubMed ID: 20023901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
    J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
    Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
    Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
    J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.